002901.SZ · 大博医疗
China A-shares · RS rating 38 · As of 2026-10-14
| Price | 39.28 CNY |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 38 / 60 / 29 / 29 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 18 / 13 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +8.9% |
| Distance from 52-week high | +33.4% |
| Market cap (USD) | $2.5B |